
Hamps Bio Limited
Hamps Bio Limited(HAMPS)
Total Shares
12,20,000
Issue Size
₹6.22 Cr
Price Band
₹51 – ₹51
Lot Size
2000 shares
Min. Investment
₹1,02,000
Max. Investment
₹1,02,000
Open Date
13 Dec, 2024
Close Date
17 Dec, 2024
Allotment
18 Dec, 2024
Listing
20 Dec, 2024
Max. Investment
₹1,02,000
Announced
13 Dec, 2024
Opening Date
13 Dec, 2024
Closing Date
17 Dec, 2024
Basis of Allotment
18 Dec, 2024
Initiation of Refunds
19 Dec, 2024
Credit of Shares
19 Dec, 2024
Listing Date
20 Dec, 2024
Apply via UPI in 5 minutes
Choose your broker • Zero commission on IPO
About Hamps Bio Limited IPO
Incorporated in 2007, Hamps Bio Limited is engaged in the marketing and distribution of pharmaceutical products like tablets, syrups, capsules, injectables, oil, and nutritional supplements.
The company distributes its products through a network of over 50 distributors and e-commerce platforms, including Amazon (US, Canada, EU), Flipkart, and Jio Mart. Their pharma products are sold in 8 states and union territories, while Freeze-dried and Frozen products reach 6 countries
Hamps Bio Limited IPO Share Price and Issue Size
Issue Breakdown
Shareholding
Dilution: 38.9% increase in shares
Hamps Bio Limited IPO Financials Health
Hamps Bio Limited IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 1 | 2000 | ₹1,02,000 |
| Retail Maximum | 1 | 2000 | ₹1,02,000 |
| HNI Minimum | 2 | 4000 | ₹2,04,000 |
(All values in CR)
Hamps Bio Limited IPO Valuation
| Metric | Value |
|---|---|
| Debt/Equity | 0.31 |
| EPS Post IPO | 1.34 |
| EPS Pre IPO | 1.6 |
| P/BV | 2.96 |
| P/E Post IPO | 38.03 |
| P/E Pre IPO | 31.94 |
| PAT Margin (%) | 7.73 |
| ROCE | 18.31% |
| ROE | 21.14% |
| RoNW | 14.84% |
(All values in CR)
Strength & Risk of Hamps Bio Limited IPO
1. Expert Leadership and Industry Experience driving Strategic Business Growth.
2. Distribution Network with Expansive E-Retailing Presence.
3. Wide and diversified range of products.
4. Diversified, global customer base with long standing relationships.
5. Wide Geographical Presence.
6. Brand Identity.
7. Quality Assurance.
1. We have certain outstanding litigation against us, an adverse outcome of which may adversely affect our business, reputation and results of operations.
2. We do not have our own manufacturing facility for pharmaceutical products and we have to rely on third parties for procuring pharmaceutical products sold by our Company.
3. Our existing manufacturing facility for freeze dried and frozen products is concentrated in a single region i.e., Ankelshwar, Gujarat and the inability to operate and grow our business in this particular region may have an adverse effect on our business, financial condition, results of operations, cash flows and future business prospects.
4. We operate in a highly regulated and controlled industry environment. Our Company operates under several statutory and regulatory permits, licenses and approvals. Our failure to obtain and/or renew any approvals or licenses in future may have an adverse impact on our business operations.
5. Our failure to comply with applicable quality standards may result in product liability claims, which could adversely affect our business, financial condition, cash flows and results of operations.
6. The availability of counterfeit drugs, such as those passed off by others as our products, and the introduction of alternative pharmaceutical products due to changes in technology or consumer needs, could adversely affect our goodwill, results of operations, financial results, and business prospects.
7. Any disruptions to the supply, or increases in the pricing, of the raw materials and finished products that we outsource, may adversely affect the supply and pricing of our products and, in turn, adversely affect our business, cash flows, financial condition and results of operations.
8. Our Group Companies has incurred losses in past financial years.
9. Our Company had negative cash flows in the past years, details of which are given below. Sustained negative cash flow could impact our growth and business.
10. We are dependent upon few suppliers for the material requirements of our Freeze dried and Frozen Products business. Further, we do not have definitive agreements or fixed terms of trade with most of our suppliers. Failure to successfully leverage our relationships with existing suppliers or to identify new suppliers could adversely affect our business operations.
Hamps Bio Limited IPO Subscription Status
| Investor Category | Subscription (times) | Shares Offered | Shares bid for | Total Amount (Rs Cr.) |
|---|---|---|---|---|
| HNI | 759.69 | 5,78,000 | 43,90,98,000 | 2 |
| Market Maker | 1.00 | 62,000 | 62,000 | 0.32 |
| Retail | 1.00 | 5,80,000 | 77,70,42,000 | 3 |
| Total | 1.00 | 11,58,000 | 1,21,61,40,000 | 6 |
Hamps Bio Limited IPO GMP
Last updated 11 Dec, 2024 · Source: aggregated grey-market dealers
| Date | IPO Price | GMP | Sub2 Sauda | Est. Listing | Est. Profit | Updated |
|---|---|---|---|---|---|---|
| 11 Dec, 2024 | 51 | ₹0▼ | -- | ₹51 (0.00%) | - | 11 Dec, 2024 |
| 12 Dec, 2024 | 51 | ₹21 | 31900 | ₹72 (41.18%) | - | 12 Dec, 2024 |
| 13 Dec, 2024 | 51 | ₹21▼ | 31900 | ₹72 (41.18%) | - | 13 Dec, 2024 |
| 14 Dec, 2024 | 51 | ₹35▼ | 53200 | ₹86 (68.63%) | - | 14 Dec, 2024 |
| 16 Dec, 2024 | 51 | ₹40▼ | 60800 | ₹91 (78.43%) | - | 16 Dec, 2024 |
| 17 Dec, 2024 | 51 | ₹45▼ | 68400 | ₹96 (88.24%) | - | 17 Dec, 2024 |
| 18 Dec, 2024 | 51 | ₹55 | 83600 | ₹106 (107.84%) | - | 18 Dec, 2024 |
| 19 Dec, 2024 | 51 | ₹55▼ | 83600 | ₹106 (107.84%) | - | 19 Dec, 2024 |
| 20 Dec, 2024 | 51 | ₹60 | 91200 | ₹111 (117.65%) | - | 20 Dec, 2024 |
Disclaimer: GMP is an unofficial signal from grey-market dealers and is not regulated by SEBI. Use it alongside subscription data and other research for informed decision-making.
How to Apply for Hamps Bio Limited IPO
Login to Your Trading App
Open Zerodha, Upstox, Groww, Angel One, or any brokerage app.
Go to IPO Section
Find Hamps Bio Limited under the IPO section. Select it and enter your bid details — choose lot size and price (cut-off price recommended).
Enter UPI ID and Submit
Provide your UPI ID linked to your bank account and submit the application.
Approve Mandate on UPI App
Open your UPI app (Google Pay, PhonePe, Paytm, BHIM) and approve the IPO payment request.
Application Confirmed
Your funds will be blocked in your account until the IPO allotment process is completed.